CoreRx and Bend Bioscience are CDMO sister companies, bringing product development and manufacturing solutions to the pharmaceutical industry in distinct ways. CoreRx focuses on formulation and analytical development, clinical manufacturing, and commercial supply of solid oral, liquid oral, and topical dosage forms. The Bend Bioscience team, as part of CoreRx, focuses on bioavailability enhancement, solid dosage form development, stabilization of biologics and vaccines, and particle engineering for pulmonary delivery. Together we’re committed to improving patients’ lives by delivering products quickly without compromising science or quality.